EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Specialty Injectables: Ten Key Markets to 2020

  • ID: 2823016
  • Report
  • May 2014
  • 63 Pages +
  • Greystone Associates
1 of 3
The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

Highlights

- Analyzes therapeutic demand drivers and evaluates specialty injectables in ten major therapeutic markets

- Analyzes design factors, material selection issues, technologies and market development issues

- Assess significant managed care, technology, and regulatory factors affecting specialty injectable drug markets.

- Provides market data and forecasts to 2020
Note: Product cover images may vary from those shown
2 of 3
1. Executive Summary

2. Anticoagulants

3. Antivirals

4. Autoimmune Diseases

5. Multiple Sclerosis

6. Diabetes

7. Hematopoietics

8. Hormone Replacement

9. Migraine

10. Osteoporosis

11. Reproductive Health
Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown
Adroll
adroll